Literature DB >> 18948383

Structural insights on physiological functions and pathological effects of alpha-synuclein.

Marco Bisaglia1, Stefano Mammi, Luigi Bubacco.   

Abstract

Alpha-synuclein is an intrinsically unfolded protein that can adopt a partially helical structure when it interacts with different lipid membranes. Its pathological relevance is linked to its involvement in several neurodegenerative disorders including Parkinson's disease, Alzheimer's disease, and dementia with Lewy bodies. Typical of such ailments is the presence of alpha-synuclein aggregates in a beta-structure that can be soluble or precipitate. This review focuses on the structural knowledge acquired in recent years on the various conformations accessible to alpha-synuclein and to its pathologically relevant mutants. Furthermore, the role of the different variables of the chemical environments that govern the equilibria among the accessible conformations is also reviewed. The hypotheses that rationalize the relevance of the individual structural features and conformations for the physiological function of the protein or for its purported pathological role are described and compared.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18948383     DOI: 10.1096/fj.08-119784

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  61 in total

1.  Backbone assignment and dynamics of human α-synuclein in viscous 2 M glucose solution.

Authors:  Kuen-Phon Wu; Jean Baum
Journal:  Biomol NMR Assign       Date:  2010-09-25       Impact factor: 0.746

2.  α-Synuclein in gut endocrine cells and its implications for Parkinson's disease.

Authors:  Rashmi Chandra; Annie Hiniker; Yien-Ming Kuo; Robert L Nussbaum; Rodger A Liddle
Journal:  JCI Insight       Date:  2017-06-15

3.  Native Top-Down Mass Spectrometry and Ion Mobility MS for Characterizing the Cobalt and Manganese Metal Binding of α-Synuclein Protein.

Authors:  Piriya Wongkongkathep; Jong Yoon Han; Tae Su Choi; Sheng Yin; Hugh I Kim; Joseph A Loo
Journal:  J Am Soc Mass Spectrom       Date:  2018-06-27       Impact factor: 3.109

Review 4.  Impact of membrane curvature on amyloid aggregation.

Authors:  Mayu S Terakawa; Yuxi Lin; Misaki Kinoshita; Shingo Kanemura; Dai Itoh; Toshihiko Sugiki; Masaki Okumura; Ayyalusamy Ramamoorthy; Young-Ho Lee
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-04-28       Impact factor: 3.747

Review 5.  Biophysics of α-synuclein membrane interactions.

Authors:  Candace M Pfefferkorn; Zhiping Jiang; Jennifer C Lee
Journal:  Biochim Biophys Acta       Date:  2011-07-28

6.  Structural reorganization of alpha-synuclein at low pH observed by NMR and REMD simulations.

Authors:  Kuen-Phon Wu; Daniel S Weinstock; Chitra Narayanan; Ronald M Levy; Jean Baum
Journal:  J Mol Biol       Date:  2009-07-01       Impact factor: 5.469

Review 7.  Interaction between alpha-synuclein and metal ions, still looking for a role in the pathogenesis of Parkinson's disease.

Authors:  Marco Bisaglia; Isabella Tessari; Stefano Mammi; Luigi Bubacco
Journal:  Neuromolecular Med       Date:  2009       Impact factor: 3.843

Review 8.  Pathological implications of nucleic acid interactions with proteins associated with neurodegenerative diseases.

Authors:  Yraima Cordeiro; Bruno Macedo; Jerson L Silva; Mariana P B Gomes
Journal:  Biophys Rev       Date:  2014-01-09

9.  Ceftriaxone blocks the polymerization of α-synuclein and exerts neuroprotective effects in vitro.

Authors:  Paolo Ruzza; Giuliano Siligardi; Rohanah Hussain; Anna Marchiani; Mehmet Islami; Luigi Bubacco; Giovanna Delogu; Davide Fabbri; Maria A Dettori; Mario Sechi; Nicolino Pala; Ylenia Spissu; Rossana Migheli; Pier A Serra; GianPietro Sechi
Journal:  ACS Chem Neurosci       Date:  2013-10-24       Impact factor: 4.418

10.  Alpha-synuclein overexpression increases dopamine toxicity in BE2-M17 cells.

Authors:  Marco Bisaglia; Elisa Greggio; Dragan Maric; David W Miller; Mark R Cookson; Luigi Bubacco
Journal:  BMC Neurosci       Date:  2010-03-25       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.